{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:51:30Z","timestamp":1760151090595,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Despite enormous improvements in pre-clinical and clinical research, acute leukemia still represents an open challenge for pediatric hematologists; both for a significant relapse rate and for long term therapy-related sequelae. In this context, the use of an innovative technology, such as induced pluripotent stem cells (iPSCs), allows to finely reproduce the primary features of the malignancy and can be exploited as a model to study the onset and development of leukemia in vitro. The aim of this review is to explore the recent literature describing iPSCs as a key tool to study different types of hematological malignancies, comprising acute myeloid leukemia, non-down syndrome acute megakaryoblastic leukemia, B cell acute lymphoblastic leukemia, and juvenile myelomonocytic leukemia. This model demonstrates a positive impact on pediatric hematological diseases, especially in those affecting infants whose onsets is found in fetal hematopoiesis. This evidence highlights the importance of achieving an in vitro representation of the human embryonic hematopoietic development and timing-specific modifications, either genetic or epigenetic. Moreover, further insights into clonal evolution studies shed light in the way of a new precision medicine era, where patient-oriented decisions and therapies could further improve the outcome of pediatric cases. Nonetheless, we will also discuss here the difficulties and limitations of this model.<\/jats:p>","DOI":"10.3390\/cells11030476","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T23:02:06Z","timestamp":1643497326000},"page":"476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?"],"prefix":"10.3390","volume":"11","author":[{"given":"Salvatore Nicola","family":"Bertuccio","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5876","authenticated-orcid":false,"given":"Davide","family":"Leardini","sequence":"additional","affiliation":[{"name":"Specialty School of Pediatrics, University of Bologna, 40138 Bologna, Italy"},{"name":"Pediatric Oncology and Hematology Unit \u201cLalla Ser\u00e0gnoli,\u201d Pediatric Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-3998","authenticated-orcid":false,"given":"Daria","family":"Messelodi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Anselmi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-2558","authenticated-orcid":false,"given":"Francesca","family":"Manente","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Ragni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-614X","authenticated-orcid":false,"given":"Salvatore","family":"Serravalle","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit \u201cLalla Ser\u00e0gnoli,\u201d Pediatric Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-057X","authenticated-orcid":false,"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"},{"name":"Pediatric Oncology and Hematology Unit \u201cLalla Ser\u00e0gnoli,\u201d Pediatric Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0379-9562","authenticated-orcid":false,"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910420408","article-title":"The international incidence of childhood cancer","volume":"42","author":"Parkin","year":"1988","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood.2021011694","article-title":"How I treat pediatric acute myeloid leukemia","volume":"138","author":"Rubnitz","year":"2021","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2018.1.307","article-title":"JMML genomics and decisions","volume":"2018","author":"Niemeyer","year":"2018","journal-title":"Hematology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved Survival for Children and Adolescents with Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report from the Children\u2019s Oncology Group","volume":"30","author":"Hunger","year":"2012","journal-title":"JCO"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","volume":"24","author":"Bolouri","year":"2018","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2016-01-695551","article-title":"Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: A retrospective intergroup study","volume":"127","author":"Masetti","year":"2016","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Almosailleakh, M., and Schwaller, J. (2019). Murine Models of Acute Myeloid Leukaemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020453"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","article-title":"Chromosome translocations and covert leukemic clones are generated during normal fetal development","volume":"99","author":"Mori","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fped.2019.00401","article-title":"Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention","volume":"7","author":"Mercher","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2010-11-317529","article-title":"Modeling human infant MLL leukemia in mice: Leukemia from fetal liver differs from that originating in postnatal marrow","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/embj.201387098","article-title":"iPS cells: A game changer for future medicine","volume":"33","author":"Inoue","year":"2014","journal-title":"EMBO J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wehbe, Z., Ghanjati, F., and Flotho, C. (2021). Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research. Cells, 10.","DOI":"10.3390\/cells10092335"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex vivo","volume":"11","author":"Pabst","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102404","DOI":"10.1016\/j.scr.2021.102404","article-title":"Modeling leukemia with pediatric acute leukemia patient-derived iPSCs","volume":"54","author":"Li","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Messelodi, D., Bertuccio, S.N., Indio, V., Strocchi, S., Taddia, A., Serravalle, S., Bandini, J., Astolfi, A., and Pession, A. (2021). iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death. Cells, 10.","DOI":"10.3390\/cells10112822"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1242\/dev.092551","article-title":"Induced pluripotent stem cells in medicine and biology","volume":"140","author":"Takahashi","year":"2013","journal-title":"Development"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.scr.2021.102460","article-title":"Generation of three iPSC lines from different types of pediatric acute leukemia patients","volume":"55","author":"Li","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bjh.12947","article-title":"How I treat paediatric relapsed acute myeloid leukaemia","volume":"166","author":"Kaspers","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fped.2015.00037","article-title":"Acute Myeloid Leukemia in Infants: Biology and Treatment","volume":"3","author":"Masetti","year":"2015","journal-title":"Front. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/stem.2655","article-title":"Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations: Human AML Reprogramming Selects for Normal Genomes","volume":"35","author":"Lee","year":"2017","journal-title":"Stem Cells"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2016.11.018","article-title":"Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease","volume":"20","author":"Chao","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102096","DOI":"10.1016\/j.scr.2020.102096","article-title":"An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects","volume":"49","author":"Yamasaki","year":"2020","journal-title":"Stem Cell Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tijchon, E., Yi, G., Mandoli, A., Smits, J.G.A., Ferrari, F., Heuts, B.M.H., Wijnen, F., Kim, B., Janssen-Megens, E.M., and Schuringa, J.J. (2019). The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226435"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2015-05-567859","article-title":"The biology of pediatric acute megakaryoblastic leukemia","volume":"126","author":"Gruber","year":"2015","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.critrevonc.2019.04.011","article-title":"The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children","volume":"138","author":"Masetti","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","article-title":"Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome","volume":"113","author":"Malinge","year":"2009","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bjh.15725","article-title":"CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity","volume":"184","author":"Masetti","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/2159-8290.CD-18-1463","article-title":"Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene\u2013Driven Myeloid Leukemia","volume":"9","author":"Lopez","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nbt.2915","article-title":"Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells","volume":"32","author":"Sturgeon","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_33","unstructured":"Tran, T.H., and Hunger, S.P. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities, Semin. Cancer Biol., in press."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.stemcr.2016.08.013","article-title":"Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency","volume":"7","author":"Prieto","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.devcel.2017.12.005","article-title":"A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1","volume":"44","author":"Richardson","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fortschegger, K., Husa, A.-M., Schinnerl, D., Nebral, K., and Strehl, S. (2021). Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147576"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Erickson, R.P., and Wynshaw-Boris, A.J. (2016). Noonan Syndrome and RAS Signaling Defects. Epstein\u2019s Inborn Errors of Development, Oxford University Press.","DOI":"10.1093\/med\/9780199934522.001.0001"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood-2013-01-478412","article-title":"Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia","volume":"121","author":"Paluru","year":"2013","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41375-018-0169-y","article-title":"Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells","volume":"33","author":"Tasian","year":"2019","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.celrep.2015.09.019","article-title":"Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia","volume":"13","author":"Sevilla","year":"2015","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.jproteome.9b00495","article-title":"Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia","volume":"19","author":"Pearson","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.celrep.2013.06.013","article-title":"Facilitates Chromatin Transcription Complex Is an \u201cAccelerator\u201d of Tumor Transformation and Potential Marker and Target of Aggressive Cancers","volume":"4","author":"Garcia","year":"2013","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"ra74","DOI":"10.1126\/scitranslmed.3002530","article-title":"Curaxins: Anticancer Compounds That Simultaneously Suppress NF-\u03baB and Activate p53 by Targeting FACT","volume":"3","author":"Gasparian","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2006-09-047704","article-title":"Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures","volume":"109","author":"Kennedy","year":"2007","journal-title":"Blood"},{"key":"ref_49","first-page":"492","article-title":"Translational models of 3-D organoids and cancer stem cells in gastric cancer research","volume":"12","author":"Wuputra","year":"2021","journal-title":"Stem Cell Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:11:09Z","timestamp":1760134269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11030476"],"URL":"https:\/\/doi.org\/10.3390\/cells11030476","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2022,1,29]]}}}